PTC Therapeutics Inc
F:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
F:BH3
|
US |
|
N
|
New Residential Investment Corp
F:14N1
|
US |
|
E
|
Everest Re Group Ltd
F:ERE
|
BM |
Shareholder Yield
Current shareholder yield for
BH3 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
BH3 Price
PTC Therapeutics Inc
| Average Annual Return | 10.65% |
| Standard Deviation of Annual Returns | 45.91% |
| Max Drawdown | -70% |
| Market Capitalization | 7B EUR |
| Shares Outstanding | 76 700 000 |
| Percentage of Shares Shorted |
N/A
|